Investigating microplastics in patients with heart attacks
Official title: Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
Run by Azienda Ospedaliera "Sant'Andrea" · NCT06965023 · Data updated 2026-11-12
This study is testing whether tiny plastic particles found in the body affect heart health in patients who have had a heart attack and are getting urgent treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Azienda Ospedaliera "Sant'Andrea" Academic / other |
| Locations | 10 sites (Roma, Rome and 9 other locations) |
| Status | Recruiting |
| Started | April 22, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT06965023 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who are experiencing a STEMI and require urgent invasive coronary angiography.
✕Probably not a fit
Patients with contraindications to percutaneous coronary intervention or those with severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the presence and impact of microplastics and nanoplastics (MNPs) in patients experiencing ST-elevation myocardial infarction (STEMI) who are undergoing urgent coronary intervention. It will assess the burden of MNPs in coronary thrombi and their association with cardiac damage, plaque vulnerability, and cardiovascular events. The study will utilize advanced imaging techniques like optical coherence tomography and cardiac magnetic resonance to evaluate the relationship between MNPs and cardiovascular health over a one-year follow-up period.
Why it matters
Potential benefit: If successful, this study could provide insights into the role of environmental pollutants in heart disease, potentially leading to improved prevention and treatment strategies.
How similar studies have gone: While the investigation of microplastics in human health is emerging, this specific approach in the context of STEMI is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All the following inclusion criteria should be fulfilled: 1. Age \> 18 years old; 2. STEMI undergoing urgent invasive coronary angiography; 3. Acute thrombotic coronary occlusion/sub-occlusion (TIMI 0/1); 4. Clinical indication to thromboaspiration; 5. Able to give informed consent. Exclusion Criteria: 1. Contraindications to percutaneous coronary intervention; 2. Hemodynamic instability or cardiogenic shock; 3. End-stage chronic kidney disease; 4. Life expectancy \< 1 year due to non-cardiac pathology.
Where it's running
-
Sant'Andrea University Hospital
Roma, Rome, Italy Recruiting -
Azienda Ospedaliera Integrata Verona, Italy
Verona, Italy Recruiting -
Department of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli
Caserta, Italy Active not recruiting -
Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy.
Caserta, Italy Not yet recruiting -
Cardiovascular Department, A.O.U. Policlinico "G. Rodolico - San Marco", University of Catania, Catania, Italy.
Catania, Italy Not yet recruiting -
Azienda Ospedaliero Universitaria di Ferrara, Cona, Italy
Ferrara, Italy Not yet recruiting
Show 4 more locations
-
Cardiovascular Division, Morgagni-Pierantoni University Hospital, Forlì, Italy.
Forlì, Italy Not yet recruiting -
Interventional Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Milan, Italy Not yet recruiting -
Department of Advanced Medical and Surgical Sciences, University of Campania-Luigi Vanvitelli, Naples, Italy.
Naples, Italy Active not recruiting -
Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
Turin, Italy Not yet recruiting
Study contacts
- Study coordinator: Emanuele Barbato, MD, PhD
- Email: emanuele.barbato@uniroma1.it
- Phone: +39 0633776115
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microplastics and nanoplastics in people with chronic coronary syndromes
This study will test whether tiny plastic particles (micro- and nanoplastics) can be detected in the coronary blood of adults with suspected or known chronic coronary syndromes who are having coronary CT and invasive angiography.
-
Microplastics in the liver of people with cirrhosis and portal hypertension
This study tests whether microplastics and nanoparticles accumulate in the livers of adults with cirrhosis and portal hypertension who are undergoing surgery or transplant, to understand where they go and what form they take.
-
Reducing slow-flow and no-reflow during STEMI with a high-dose intracoronary adenosine protocol
In STEMI patients undergoing primary PCI, this trial tests whether giving a high-dose intracoronary adenosine before balloon or stent inflation can prevent slow-flow or no-reflow.
-
Drug-coated balloons vs drug-eluting stents for immediate slow-flow/no-reflow in STEMI with high thrombus
This study tests whether using a drug-coated balloon instead of a drug-eluting stent during PCI helps reduce immediate slow-flow or no-reflow in STEMI patients with high thrombus burden.
-
CHIP in STEMI: Does clonal hematopoiesis influence infarct severity
This study tests whether clonal hematopoiesis (CHIP) affects infarct size and microvascular injury in people having a heart attack treated with PCI.
-
Digitally supported personalized nutrition to improve heart pumping after ST‑elevation heart attack
This program will test whether a three-month personalized diet plan with digital support can improve heart pumping (left ventricular ejection fraction) in adults who recently had a STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.